By Jess Jones The chief executive of Google DeepMind has said artificial intelligence (AI) could be designing drugs in clinics within the next couple of years. Demis Hassabis, who founded DeepMind in the UK in 2010, said AI will have a “material impact on drug discovery.” “I think in the next couple of years we’re going to start seeing AI design drugs in the clinic,” he said, speaking to an audience of global telecoms industry players gathered at the Mobile World Congress in Barcelona on Monday afternoon. Deepmind, bought by Google in 2014, is an AI research lab and the creator of a system cal…